
Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
Jun 15, 2026 - 25:13
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
After 20 years of platform building and resets, Arrowhead Pharmaceuticals is making a bid to become a large-cap biotech. On the latest BioCentury This Week podcast, BioCentury’s analysts discuss how the company has built...
Ep. 356 - Arrowhead’s arc. Plus: AI in biotech venture, Synnovation, MFN is an episode from BioCentury This Week by BioCentury. After 20 years of platform building and resets, Arrowhead Pharmaceuticals is making a bid to become a large-cap...
This episode belongs to BioCentury This Week.
Use the player on this page to stream the episode online.
Published Mar 24, 2026, 33:59 long, audio available.